Inspection Record

Wyeth Pharmaceutical,Div Wyeth Holding Corp — FDA 483 Findings

US FDAInspected 2015-07-24Published 2024-01-17 4 findingsOther quality systemLabeling and packagingEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

As part of your Master Corrective action plan established to test minerals under LIR commitment only 4 of 5 corrective actions were implemented.

2Labeling and packaging

In the packaging area, failure to demonstrate all requirements were met.

3Other quality system

Failure to use an appropriate scientifically valid method to test the seal over plastic bottles to ensure uniformity of the sealing process across all plastic bottles.

4Equipment and facility

Your hand washing facility does not dispense water at a suitable temperature.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Wyeth Pharmaceutical,Div Wyeth Holding Corp company profile — full history US FDA documents, 2024 Go to Findings search